BACKGROUND: Atrial fibrillation (AF) is frequently associated with enhanced inflammatory response. The NLRP3 (NACHT, LRR, and PYD domain containing protein 3) inflammasome mediates caspase-1 activation and interleukin-1β release in immune cells but is not known to play a role in cardiomyocytes (CMs). Here, we assessed the role of CM NLRP3 inflammasome in AF.
A trial fibrillation (AF) is the most common cardiac arrhythmia, with increasing prevalence worldwide. 1 An enhanced inflammatory response is frequently observed in patients with AF. [2] [3] [4] [5] [6] Increased circulating levels of proinflammatory cytokines interleukin (IL)-1β, IL-18, and tumor necrosis factor α correlate with AF progression in patients. 3, [7] [8] [9] Moreover, the level of inflammatory cytokines can predict adverse outcomes after AF ablation. [10] [11] [12] However, the precise role of inflammatory signaling in AF pathogenesis remains elusive.
The NLRP3 (NACHT, LRR, and PYD domain containing protein 3) inflammasome is a key inflammatory signaling complex that regulates innate immunity. 13, 14 Activation of the NLRP3 inflammasome requires 2 processes: (1) a priming event that induces transcription of NLRP3 and precursor caspase-1 (pro-Casp1) via toll-like receptor NFκB signaling, and (2) a subsequent triggering mechanism that promotes the assembly of NLRP3, adaptor-protein apoptosis-associated speck-like protein containing a CARD (ASC) and pro-Casp1, leading to auto-cleavage of pro-Casp1 into active caspase-1 (Casp1) heterodimers comprised of p20 and p10 subunits. 14, 15 In immune cells, active Casp1 cleaves pro-IL-1β and pro-IL-18, releasing the active products IL-1β and IL-18. 16, 17 Although several studies have suggested a role for NLRP3 inflammasome activation in the development of cardiomyopathy, [18] [19] [20] the function of NLRP3 in cardiomyocytes (CMs) remains largely unknown. In addition, whether the NLRP3 inflammasome affects cardiac electrophysiological function has not been established. Here, we sought to determine whether CM NLRP3 inflammasome activation is involved in the pathogenesis of AF.
METHODS
Expanded methods are available in the online-only Data Supplement. The data, methods, and study materials will be made available to other researchers on request.
Human Atrial Samples
Right atrial appendages of patients undergoing open heart surgery for coronary bypass grafting or valve replacement were collected with patients' written informed consent. All experimental protocols were approved by the institutional review committee of the Medical Faculty Mannheim, University Heidelberg (2011-216 N-MA) and Carl Gustav Carus Medical Faculty, Dresden University of Technology (EK790799) performed in accordance with the Declaration of Helsinki. After excision, atrial appendages were snap-frozen in liquid nitrogen for biochemical studies. Patient demographics and characteristics are listed in Tables  I and II 
Preparation of CM-Enriched Cell Pellets From Human Atrial Biopsies
BSA gradient filtration was performed to obtain CM-enriched cell pellets as previously described. 21, 22 Briefly, after collagenase/protease enzymatic dissociation of right-atrial tissue samples and centrifugation, cells were resuspended at room temperature in Ca 2+ -free Tyrode's solution containing 0.1% BSA. Cell suspensions were layered over a 6% BSA gradient (Ca 2+ -free Tyrode's solution), and cells were allowed to sediment for 45 minutes. Cell debris and undigested tissue fragments were largely located in the upper part of the 6% BSA fraction, whereas noncardiomyocytes (mostly fibroblasts) were mainly retained at the phase boundary between 0.1% and 6% BSA. Atrial CMs were enriched at the bottom of the gradient as verified by light microscopy and were used for subsequent biochemistry experiments.
Dog Atrial Samples and CMs
Mongrel dogs (20-36 kg) were divided into control and atrial tachycardia pacing (ATP, 400 bpm for 1 week) groups. Animal care procedures followed National Institutes of Health guidelines and were approved by the Animal Research Ethics Committee of the Montreal Heart Institute. The animal model was prepared as previously described in detail. 23 Hearts were excised via a left thoracotomy and immersed in oxygenated Tyrode's solution containing (in mmol/L) 136 NaCl, 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 0.33 NaH 2 PO 4 , 10 glucose, and 5 HEPES (pH 7.4). Right atrial CMs were isolated as previously described in detail. 24 Whole-tissue samples and CM aliquots from the right atria were snap-frozen for biochemical studies.
Animal Studies
All studies involving mice were performed according to protocols approved by the Institutional Animal Care and Use
Clinical Perspective
What Is New?
• This is the first study to demonstrate a causal link between the NLRP3 (NACHT, LRR, and PYD domain containing protein 3) inflammasome (an innate inflammation signaling complex) and the pathophysiology of atrial fibrillation (AF).
• The activity of the NLRP3 inflammasome in atrial cardiomyocytes is enhanced in patients with paroxysmal or long-lasting persistent AF.
• Constitutive activation of the cardiomyocyte NLRP3
inflammasome in an animal model produces ectopic activity and a re-entry substrate for AF development.
What Are the Clinical Implications?
• We discovered a novel paradigm of disease-inducing inflammasome-mediated signaling in nonimmune cells.
• Targeting the NLRP3 inflammasome is a novel therapeutic possibility for AF. 
Telemetry Studies
Telemetry ECG recordings were acquired to evaluate the occurrence of spontaneous arrhythmias in conscious and ambulatory mice. ECG radio telemeters (Data Sciences International) were implanted intraperitoneally, as described. 27, 29 Telemetry analyses were performed by an independent person blinded to mouse genotypes. Premature atrial contraction was defined by the occurrence of a premature P-wave with an abnormal morphology, followed by a conducted QRS complex. The number of premature atrial contraction events recorded between 6 and 8 pm was counted.
Programmed Intracardiac Stimulation
Programmed intracardiac stimulation was performed to assess AF inducibility as described. 27, 30, 31 Briefly, AF was induced by an overdrive pacing protocol, starting with 2-second burst pacing at a cycle length of 40 ms and decreasing in each successive burst by a 2-ms decrement to a cycle length of 10 ms. AF was defined as the occurrence of rapid, fragmented atrial electrograms with irregular R-R intervals lasting ≥1 second. To determine whether AF inducibility was reproducible, mice were subjected to the same atrial burst-pacing protocols 3 times, and only the mice that exhibited 2 or 3 times the AF evoked by burst pacing were considered AF-positive. The incidence of inducible AF was calculated as the percentage of the AF-positive mice divided by the total number of mice studied. The experimenter was blinded to genotype or viral gene-transfer status of mice.
Optical Mapping
Anesthetized mice were injected with 100 U of heparin intraperitoneally. After cervical dislocation, hearts were removed and washed in oxygenated (95% O 2 /5% CO 2 ), cold Tyrode's solution containing 1.3 mmol/L CaCl 2 . Then hearts were cannulated via the aorta, retrograde perfused, and superfused with Tyrode's solution (2-5 mL/min), and the aortic pressure was kept between 80 and 120 mm Hg. Right atrial epicardial pacing was achieved with a PowerLab 26T stimulator (AD Instruments). Hearts were loaded with 0.5 µmol/L blebbistatin (Sigma-Aldrich) to eliminate motion artifact and stained with 0.1 µmol/L voltage-sensitive dye RH237 (Invitrogen). An LED light was used with an excitation wavelength of 530 nm. The emitted fluorescence V m signal was long-passed (>700 nm) and acquired via an MiCAM CMOS camera (SciMedia). The surface ECG was recorded continuously. The atrial effective refractory period (AERP) was assessed with S1-S2 pacing at a cycle length of 100 ms.
Whole-Cell Patch Clamp
The Kv1.5-carried ultra-rapid delayed rectifier potassium current (I Kur ) was assessed with a Port-a-Patch (Nanion Technologies) connected to an EPC10-USB amplifier (HEKA Instruments) as previously described. 32 Borosilicate glass microelectrodes had tip resistances of 2 to 3.5 mol/MΩ. Once gigaseal resistances were achieved, series resistance and cell capacitance were compensated. Currents were elicited with 200-ms pulses from a holding potential of −80 to 40 mV applied at 30-second intervals. Myocytes were superfused with buffer containing (in mmol/L) 160 NaCl, 4. 33 applied via a rapid solution-exchange system. I Kur was defined as the DPO-1-sensitive decrease in total steadystate peak current expressed as density (pA/pF).
Adeno-Associated Virus (AAV) Production and Delivery
The plasmid AAV-stop-GFP vector 34 was a gift from Dr Matthias Klugmann (University of New South Wales, Australia). The mCherry-tagged shNlrp3 targeting the sequence of ggttctactctatcaaggaca at site 654 of mus musculus Nlrp3 (NM_145827.3) or scrambled sequence were obtained from GeneCopoeia and were cloned into the Mlu I site of the plasmid AAV-stop-GFP vector to replace the GFP sequence. The adenoviral helper plasmid pAdDeltaF6 (PL-F-PVADF6) and the AAV9 packaging vector plasmid AAV2/9 (PL-T-P0008-R 2 ) were obtained from Puresyn Inc. AAV9 was packaged in HEK293T cells by the triple transfection method and purified by CsCl density gradient centrifugation as described. 35, 36 Two-monthold CM-specific knockin mouse model expressing constitutively active NLRP3 (CM-KI) mice were injected with 1 dose of AAV9-scramble or AAV9-shNlrp3 virus (5×10 11 genome copy/ mouse) via the retro-orbital route.
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Statistical Analysis
For numeric data that were presented as mean±SEM, a 2-tailed Student's t test was used for data comparison of 2 groups with normal distribution; 1-way ANOVA and Holm-Sidak's test were used for data comparison of multiple groups with normal distribution; and Mann-Whitney and Kruskal-Wallis tests followed by Dunn's test were used to compare groups when the data were not normally distributed. Fisher's exact or χ 2 tests were used to compare categorical data. A P value <0.05 was considered statistically significant.
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RESULTS
Enhanced Activity of NLRP3 Inflammasomes in Patients With AF
To determine whether the activation of NLRP3 inflammasomes is altered in patients with AF, we assessed the protein levels of NLRP3, ASC, and active Casp1-p20 in atrial whole-tissue lysates from patients with a history of paroxysmal (pAF) or long-standing persistent (chronic) AF (cAF). Although protein levels of NLRP3 remained unchanged, levels of active Casp1-p20 were significantly increased, indicating increased NLRP3 inflammasome activity in the atria of patients with pAF compared with sinus-rhythm controls with no history of AF (Ctl) (P<0.05) (Figure 1A and 1B; patient characteristics in Table I in the online-only Data Supplement). Total and phosphorylated NFκB were unchanged in patients with pAF, suggesting that assembly (triggering) is the major mechanism for NLRP3 inflammasome activation ( Figure IA and IB in the online-only Data Supplement). In contrast, protein levels of NLRP3, ASC, and Casp1-p20 were all increased in patients with cAF compared with Ctl ( Figure 1C and 1D), indicating that besides triggering, priming of NLRP3 inflammasomes accompanies AF progression to persistent In addition, dogs subjected to AF mimicking ATP 38 also showed increased expression of active Casp1-p20 without changes in NLRP3 or ASC ( Figure 1E and 1F). Similarly, CREM-TG mice that develop spontaneous AF and recapitulate the progressive nature of AF seen in humans 26,27 also showed increased atrial levels of NLRP3, ASC, and Casp1-p20 at 2 months of age, along with atrial ectopic events, before the onset of spontaneous AF ( Figure 1G and 1H) . Upregulation of the NLRP3 inflammasome components in CREM-TG mice was associated with an enhanced activation of toll-like receptor 4 NFκB pathways ( Figure IE and IF in the online-only Data Supplement) and an increased nuclear localization of phosphorylated NFκB ( Figure IG and IH in the online-only Data Supplement).
Because NLRP3 inflammasomes play an important role in innate immune cells, we assessed whether enhanced macrophage infiltration might contribute to AF development in patients. The protein levels of CD68-a macrophage marker-were unchanged in patients with pAF but increased in cAF ( Figure ), 39 increased macrophage NLRP3 inflammasome activity 39 did not increase AF inducibility ( Figure IIC in the online-only Data Supplement). These results suggest that macrophage NLRP3 activation is insufficient to cause AF, and macrophage NLRP3 is unlikely to account for clinical AF, pointing to a role for NLRP3 in other cell types. To further determine whether the activity of the NLRP3 inflammasome increases in CMs of patients with AF, we separated atrial CMs from other atrial cell types, mostly cardiac fibroblasts (CFs) (Figure 2A, upper) . Moreover, these CM and CF preparations were negative for the highly specific macrophage/eosinophilic granulocyte marker F4/80 40, 41 ( Figure 2A, lower) , suggesting that the levels of macrophages/eosinophilic granulocytes in the human atrium (as a source of NLRP3 inflammasome) are rather low and lie below the detection limit of Western blotting. Consistent with the findings in atrial whole-tissue lysates, the activity of NLRP3 inflammasome was increased (reflected by the increased level of active Casp1-p20) in the atrial CMs of patients with pAF and cAF compared with Ctl ( Figure 2B through 2E) , as well as in the atrial CMs of ATP compared to Ctl dogs 42 ( Figure 2F and 2G). Overall, these results indicate that increases in NLRP3 inflammasome in CMs might contribute to the evolution of atrial remodeling that promotes AF induction and maintenance.
CM-Specific Activation of NLRP3 Enhances AF Susceptibility
To test whether CM-restricted activation of NLPR3 is sufficient to promote AF, we developed CM-specific knockin mice expressing a gain-of-function NLRP3 (Myh6 . 25, 43 Quantitative polymerase chain reaction and immunocytochemistry confirmed expression of NLRP3 in atrial CMs of CM-KI mice ( Figure III in the online-only Data Supplement). The A350V mutation in NLRP3 facilitates interdomain interactions, leading to constitutive activation of NLRP3 inflammasomes. 25 Similar to patients with pAF, 2-month-old CM-KI mouse atria showed unchanged protein expression of NLRP3 and ASC compared with Ctl, including WT and Myh6
Cre mice ( Figure 3A ), whereas Casp1-p20 was significantly upregulated (P<0.05) ( Figure 3B ), confirming constitutive activation of NLRP3 inflammasomes in CM-KI mouse CMs.
To determine whether CM-restricted activation of NLRP3 inflammasomes promotes atrial arrhythmias, we performed ECG telemetry recordings. At 3 months of age, baseline ECG parameters (RR, HR, PR, QRS, QTc), sinus node recovery time, atrioventricular node effective refractory period, and ventricular effective refractory period were unaltered in CM-KI mice (Table III and Figure  IV in the online-only Data Supplement), suggesting that the conduction system and ventricular electrophysiology were not affected in CM-KI mice. Further analysis of 2-hour recordings between 6 and 8 pm showed that premature atrial contraction events were significantly more frequent in CM-KI mice (13.3±3.9 events, n=8) versus Ctl mice (1.7±0.5 events, n=7, P<0.05) ( Figure 3C and 3D) . These results indicate that CM-KI mice exhibit atrial ectopic activity that might contribute to AF initiation. To verify whether an AF-maintaining substrate also developed, we performed programmed electric stimulation as previously described. 27, 30, 31 The incidence of reproducible pacing-induced AF was significantly higher in CM-KI mice (88.9%, n=9, P<0.05) than in Ctl mice (15.4%, n=13) ( Figure 3E and 3F). These findings suggest that CM-KI mice likely develop a substrate for AF. Echocardiography revealed that left ventricular ejection fraction was mildly reduced in 3-month-old CM-KI mice (Table IV and Figure V in the online-only Data Supplement), suggesting that the enhanced susceptibility to AF in CM-KI mice is not caused by clinically relevant ventricular dysfunction. It is important to note that a newly developed selective inflammasome inhibitor MCC950 (10 mg/kg IP daily for 10 days) that interrupts assembly of the NLRP3 inflammasome complex 44 prevented AF inducibility in CM-KI mice (0%, n=4, P<0.05 versus CM-KI) ( Figure 3F ), validating the notion that enhanced NLRP3 inflammatory signaling is sufficient and necessary for AF susceptibility in CM-KI mice. Similar to the results of patients with AF, protein levels of CD68
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were unchanged in 2-month-old CM-KI mice ( Figure 3G ), arguing against significant contributions of macrophage activation to AF promotion in 2-month-old CM-KI mice. Despite unchanged CD68 abundance, levels of IL-1β protein were increased in CM-KI mice as early as 2 months of age and further increased at 7 months ( Figure 3G ).
CM-Specific Activation of NLRP3 Promotes Abnormal Sarcoplasmic Reticulum (SR) Ca 2+ Release and Electrical Remodeling
To study the consequences of CM NLRP3 inflammasome activation for atrial electrophysiology, we assessed the electric activation pattern in CM-KI mice atria by optical mapping. We found that CM-KI mice manifested ectopic activity that can initiate premature atrial contractions more frequently than Ctl mice (85% versus 12%, P<0.05) ( Figure 4A through 4C ). Emerging evidence shows that abnormal SR Ca 2+ release frequently underlies ectopic activity. 30, [45] [46] [47] We therefore assessed intracellular Ca 2+ homeostasis in the atrial CMs of CM-KI mice using confocal imaging. Although fractional Ca 2+ release and decay of Ca 2+ transients ( Figure 4D through 4F) were similar in both groups, suggesting that systolic Ca 2+ release was not altered in CM-KI mice, the frequency of spontaneous SR Ca 2+ -release events (Ca 2+ spark frequency) 
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was significantly increased in atrial CMs from CM-KI mice ( Figure 4G ). These data indicate that the function of ryanodine receptor type-2 (RyR2) clusters is augmented in CM-KI mice potentially because of increased RyR2 phosphorylation or increased total RyR2 protein expression. 29, 48 Western blotting showed that the relative levels of phosphorylated RyR2-pS2808 (protein kinase A phosphorylation site) and RyR2-pS2814 (CaMKII phosphorylation site) to total RyR2 were unchanged in CM-KI mice (Figure 4H ), suggesting that protein kinase A-and CaMKII-mediated posttranslational modification was not altered in CM-KI mice. In contrast, total RyR2 protein levels were upregulated by ≈60% in CM-KI atria compared with Ctl (P<0.05) ( Figure 4H ), similar to results in patients with pAF. 30 Increased RyR2 expression was atrial-specific in CM-KI mice because both the protein and phosphorylation levels of RyR2 were similar in the ventricles of Ctl and CM-KI mice ( Figure In addition to ectopic activity, CM-KI mice also had abbreviated AERP ( Figure 4I ), which provides a validated substrate for AF-promoting re-entry. 49, 50 To examine how abnormal NLRP3 inflammasome activation in CMs leads to electrical remodeling, we evaluated the expression of genes encoding I Kur , acetylcholine-activated K + current (I K,ACh ), and L-type Ca 2+ current (I Ca,L ), which are known to contribute to electrical remodeling in AF. [51] [52] [53] Quantitative polymerase chain reaction analysis showed that CM-KI mice exhibited a pronounced increase in the mRNA level of Kcn5a (encoding the Kv1. (Figure 4J and 4K) . These results provide a potential molecular mechanism underlying the abbreviation of AERP (electrical remodeling) caused by constitutive activation of NLRP3 in this model.
CM-Specific Activation of NLRP3 Promotes Structural Remodeling
To elucidate whether CM NLRP3-inflammasome activation also promotes structural remodeling, we assessed atrial morphology. CM-KI mice exhibited larger atria, along with an increased ratio of atrial weight to tibia length (P<0.05 versus Ctl) ( Figure 5A and 5B), whereas the ratio of ventricular weight to tibia length was unchanged (P=0.153) ( Figure VIII in the online-only Data Supplement), suggesting that atrial hypertrophy may be a primary consequence of increased activity of atrial NLRP3 inflammasome. Atrial hypertrophy in CM-KI mice was associated with enhanced CaMKII-mediated hypertrophic signaling because Mef2c (activated by CaMKII signaling) ( Figure 5C ) 54 was upregulated in CM-KI mice. In contrast, Rcan1, a prohypertrophic regulator of calcineurin-nuclear factor of activated T-cells signaling, 55 was downregulated ( Figure 5C ). Masson trichrome staining demonstrated 
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atrial fibrosis in CM-KI mice ( Figure 5D and 5E). The mRNA levels of the fibrosis markers Col1a (encoding collagen 1a) and Lgals (encoding galectin 3) were increased in CM-KI mice ( Figure 5F ), suggesting CF activation.
56-58
CM-Specific Inhibition of NLRP3 Reduces AF Inducibility
To further evaluate the role of NLRP3 in AF development, we developed an AAV9 to knock down Nlrp3 specifically in CM-KI mouse CMs ( Figure 6A ). We injected 2-month-old CM-KI mice with either AAV9-scramble or AAV9-shNlrp3 (5×10 11 GC/mouse) virus. Four weeks later, quantitative polymerase chain reaction confirmed that Nlrp3 mRNA was reduced by 87% in the atria of CM-KI mice treated with AAV9-shNlrp3 (P<0.01 versus AAV9 scramble-treated CM-KI) ( Figure 6B ). CM-specific knockdown of Nlrp3 restored the levels of Ryr2, Kcna5, Girk1, and Girk4 mRNAs (upregulated in CM-KI mice) toward Ctl values ( Figure 6C ). AAV9-shNlrp3 reduced the incidence of inducible AF in CM-KI mice (20.0% versus 77.8% in AAV9 scramble-treated CM-KI mice, P<0.05) (Figure 6D and 6E) .
Genetic Inhibition of NLRP3 Prevents Spontaneous AF in CREM-TG Mice
To establish whether NLRP3 is involved in the development of spontaneous AF in an established mouse model, we sought to determine whether the inhibition of NLRP3 could prevent spontaneous AF in CREM-TG mice, which exhibited minimal ventricular dysfunction without β-adrenoceptor stimulation. 27, 59 It is important to note that the NLRP3 inflammasome activity was increased in CREM-TG mice at 2 months of age, before the onset of spontaneous AF (Figure 1G and 1H) . To inhibit NLRP3, we crossbred CREM-TG mice with NLRP3
-/-mice. The offspring of CREM-TG:NLRP3
-/-double-mutant (DM) mice exhibited Mendelian inheritance and were maintained on a mixed genetic background. The levels of CREM transcript in CREM-TG and DM mice were similar ( Figure IXA in the online-only Data Supplement), excluding a potential differential impact of uneven expression of CREM protein on atrial electrophysiology. The level of active Casp1-p20 was reduced in DM mice ( Figure 7A and 7B) , suggesting reduced NLRP3 inflammasome activation. Twenty-four-hour ECG recordings 
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revealed that 67% of CREM-TG mice (n=6) developed spontaneous AF, whereas spontaneous AF was absent in WT littermates (0%, n=7, P<0.05) ( Figure 7C and 7D) . None of the DM mice (n=7, P<0.05 versus CREM-TG mice) exhibited spontaneous AF ( Figure 7C and 7D) at 7 months of age. Echocardiography demonstrated that the left atrial chamber area was significantly reduced in DM compared with CREM-TG mice ( Figure 7E and 7F) at 7 months of age, suggesting that NLRP3 inhibition prevents the structural substrate for AF 25 in this model.
DISCUSSION
In this study, we discovered that the activity of NLRP3 inflammasomes is enhanced in atrial cardiomyocytes of patients with AF and dogs subjected to atrial tachycardia pacing (ATP dogs). CM-restricted activation of NLRP3 in mice promotes both the ectopic-firing and AF-maintaining substrate that ultimately leads to AF. These results provide new pathophysiological insights of potential therapeutic relevance into a common and challenging cardiac condition. Furthermore, they put forward a novel paradigm of disease-inducing inflammasome-mediated signaling in nonimmune cells. Our proposed working model of the NLRP3 activationmediated AF mechanisms is multifactorial ( Figure 7G ). On the one hand, overactive CM NLRP3 signaling enhances the expression of Ryr2, leading to increased protein expression and RyR2-mediated arrhythmic SR Ca 2+ release events, 30 which ultimately cause ectopic firing via the generation of delayed afterdepolarizations. Meanwhile, overactive NLRP3 signaling in CMs enhances the transcription of Kcna5, which could lead to augmented I Kur that abbreviate AERP, creating a re-entry substrate. On the other hand, the enhanced activation of NLRP3 inflammasomes in atrial CMs could increase Casp1 cleavage and Casp1-mediated pyroptosis, 60 which can activate CFs via danger-associated molecular factors (eg, ATP, DNA, etc). Thereafter, activated CMs and CFs can secrete inflammatory cytokines (and collagen), recruit macrophages and other immune cells, and induce fibrosis, promoting the development of an AF-maintaining substrate.
Despite the increasing evidence demonstrating a clear association between the level of inflammatory cytokines and AF progression in patients, 3, [7] [8] [9] [10] [11] [12] it is unclear which and whether inflammatory signaling pathways play a direct role in AF promotion. The NLRP3 inflammasome is a well-established signaling pathway responsible for IL-1β and IL-18 releases from innate immune cells. NLRP3 inflammasome signaling has never been linked to arrhythmogenesis before this study. Our results point to enhanced activation of NLRP3 inflammasomes in patients with both pAF and cAF. The activity of NLRP3 inflammasomes is altered not only in patients with AF but also in a dog model of atrial tachycardia remodeling and in a murine model of spontaneous AF (CREM-TG mice), establishing a major role for NLRP3 inflammasome in AF pathophysiology in the context of different pathologies. To the best of our knowledge, our study is the first to demonstrate a direct relationship between the augmented activity of NLRP3 inflammasomes in atrial cardiomyocytes and AF in patients.
The canonical function of NLRP3 in immune cells, such as macrophages, T-lymphocytes, eosinophils/neutrophils, and so on, is to facilitate the oligomerization of the inflammasome, thereby activating Casp1 and promoting the release of IL-1β and IL-18. 15, 25, 61 Our results demonstrate a novel noncanonical role of NLRP3 inflammasomes in excitable cells like atrial CMs. Using a unique CM-specific knockin model producing NLRP3 gain of function, we demonstrated detrimental cardiac electrophysiological consequences resulting from the CM-specific activation of NLRP3. The constitutive activation of CM NLRP3 inflammasomes led to an array of well-known arrhythmic events, including frequent ectopic activity and AF susceptibility. Ectopic activity because of increased SR Ca 2+ release events via RyR2 clusters can initiate AF, whereas electrical remodeling like AERP shortening and atrial fibrosis can provide a substrate for AF maintenance. 62 Our results have thus revealed a multifunctional role of inflammatory signaling in promoting AF pathophysiology.
The proarrhythmic consequences of increased RyR2 protein levels as a molecular correlate of triggered (ectopic) activity are supported by a number of previous studies in human atrial CMs or mouse models, which have shown that the abnormal SR Ca 2+ release via RyR2 promotes delayed afterdepolarizations by enhancing the activity of Na + /Ca 2+ exchanger. 27, 45, 63 Many binding partners of RyR2 (such as FKBP12.6 and junctophilin-2) can stabilize RyR2 channels in the closed state. 64, 65 When RyR2 protein levels are increased, the stoichiometry between RyR2 and its binding partners could be disproportionally altered; thus, despite the unchanged phosphorylation level of RyR2 channels (a known mechanism causing hyperactive RyR2), the extra unbound RyR2 channels could be hyperactive because of the lack of the stabilizing binding partners. 29 Furthermore, the increased numbers of RyR2 channels may cause the formation of larger RyR2 clusters, releasing more Ca 2+ during activation. In addition, a reduced distance between the RyR2 clusters may also improve synchronization between RyR2 clusters. Further extensive work is needed to directly address these possibilities.
Recent work by Bruchard et al 66 has shown that NLRP3 could act as a coactivator of transcription factor interferon regulatory factor 4 in T lymphocytes to promote T helper type 2 (T H 2) cells differentiation, in addition to its canonical function. Our data demonstrate that NLRP3 activation enhances the mRNA expression of key ion channel subunits (RyR2, Kv1.5, GIRK1, and GIRK4) involved in AF arrhythmogenesis, whereas CM-specific knockdown of Nlrp3 via AAV9-mediated gene transfer reverses their overexpression. These results support an alternative function of NLRP3 in modulating gene transcription or RNA stability. Further investigation is required to elucidate the precise mechanisms by which the inflammasome complex alters the expression of ion channel subunits.
Emerging evidence supports a synergistic action of CMs and CFs in promoting a substrate for AF development, 67 and fibrosis inevitably increases the heterogeneity of conduction, producing a re-entrant substrate for AF maintenance. 57 The elevated levels of collagen-1a and galectin-3, both markers of fibrosis, in CM-KI mice suggest that the CF activation is induced by CM-restricted NLRP3 inflammasome upregulation. This could be explained by the fact that CFs also express NLRP3 inflammasomes that can be activated by danger associated molecular patterns like ATP and DNA fragments released from CMs (Figure 7G) . 68, 69 Previous work has shown that activation of NLRP3 inflammasomes can activate gasdermin-D, which promotes the formation of permeable pores in immune cells. 70 Similarly, we speculate that NLRP3 activation could promote the release of danger associated molecular patterns from CMs into the extracellular space to activate CFs, further promoting cytokine release and collagen production ( Figure 7G) . Alternatively, the active Casp1 could also promote pyroptosis, a type of programmed cell death. 60, 71 Because CMs undergo pyroptosis in response to mature Casp1, this would also cause the release of danger associated molecular patterns. Our results point to a novel form of interplay between CMs and CFs caused by the activation of NLRP3 inflammasomes. Future studies are required to establish the potential role of the NLRP3 inflammasome in CFs for AF pathophysiology.
Because CM NLRP3 inflammasome activation can promote ectopic activity and re-entry, both critical components of AF pathophysiology, NLRP3 inhibition might be a potentially effective intervention in AF. In the light of the recent CANTOS trial 72 showing that anti-IL-1β neutralizing antibody can be beneficial in reducing cardiac events, one might speculate that therapeutic targeting of the NLRP3 inflammasome could be a viable therapeutic option for certain forms of AF. Here, we found that pharmacological inhibition by MCC950, AAV9-mediated small hairpin RNA gene transfer to knockdown NLRP3, or genetic inhibition by NLRP3 knockout prevented the development of AF. These results point to potential novel anti-AF approaches. Several pharmacological inhibitors of NLRP3 inflammasomes have been developed, like Casp1 inhibitors (Ac-YVAD-cho, Ac-YVAD-CMK, etc), the IL-1β inhibitor canakinumab, and the IL-1β receptor antagonist anakinra. 15, 73 ,74 MCC950 appears to be a highly selective NLRP3 inhibitor. 44, 73 Given the substantial limitations of current AF therapies, the establishment of new targetable pathophysiological mechanisms like those related to NLRP3 inflammasome activation is of great clinical importance. Further extensive experimentation would be required to evaluate whether these pharmacological options are beneficial in preventing the onset of AF or reducing AF burden in both animal models of AF and AF patients with activated NLRP3 inflammasome.
Our study has several limitations. First, although our data revealed an enhanced activity of NLRP3 inflammasome in CMs of AF patients, the detailed upstream factors causing the activation of NLRP3 inflammasome were not investigated in the current study. Due to the limited amount of human atrial tissue available to us, we were unable to prepare nuclear fractions from human atrial biopsies to assess the nuclear levels of phosphorylated NFκB in patients with AF. Thus, it is unclear whether an enhanced nuclear translocation of phosphorylated NFκB contributes to the activation of NLRP3 inflammasome in AF patients. In addition, because Myh6 Cre is expressed in both atrial and ventricular CMs, the constitutively active NLRP3 should affect both atrial and ventricular functions in the CM-KI model. However, ventricular function was only mildly altered at the age we investigated. A similar atrial-specific remodeling response was seen in an intense exercise-induced AF model, 75 in which tumor necrosis factor α (a proinflammatory regulator interacting importantly with NLRP3 activation) 76 was implicated for atrial remodeling and AF promotion. 75 Nevertheless, an atrial-specific knockin or knockout of NLRP3 would be the ultimate model to demonstrate that the enhanced atrial NLRP3 activity is the primary cause underlying AF development. Finally, although MCC950 effectively reduced AF inducibility in CM-KI mice, we did not determine the precise pharmacokinetics of MCC950 and its potential adverse effects on ventricular function. Future work is needed to address these important aspects.
In summary, our work has demonstrated that NLRP3 inflammasome activation in atrial cardiomyocytes is associated with the pathogenesis of AF. Cardiomyocyterestricted activation of NLRP3 is sufficient and required to promote AF and the underlying atrial remodeling events. To our knowledge, this study is the first to demonstrate a mechanistic link between NLRP3 inflammasome signaling and the pathophysiology of arrhythmias like AF. Our results suggest that inhibition of the NLRP3 inflammasome prevents AF promotion and may constitute a novel anti-AF approach targeting both electrical and structural remodeling. 
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